During the past decade, Atlanta VA Medical Center conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 60 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 29 clinical trials were completed. i.e. 103.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta VA Medical Center" #1 sponsor was "Eastern Cooperative Oncology Group" with 35 trials, followed by "Emory University" with 31 trials sponsored, "National Cancer Institute (NCI)" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored and "SWOG Cancer Research Network" with 13 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta VA Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 151 different institutions and companies that were collaborators in the rest 113 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta VA Medical Center" are "Prostate Cancer" (14 trials), "Lung Cancer" (12 trials), "Colorectal Cancer" (11 trials), "Head and Neck Cancer" (11 trials) and "Coronary Artery Disease" (10 trials). Many other conditions were trialed in "Atlanta VA Medical Center" in a lesser frequency.

Most popular intervention types in "Atlanta VA Medical Center" are "Drug" (136 trials), "Other" (56 trials), "Biological" (49 trials), "Procedure" (39 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Laboratory Biomarker Analysis" (15 trials), "paclitaxel" (12 trials), "fluorouracil" (10 trials) and "carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta VA Medical Center" are 187 trials for "All" genders, 24 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Atlanta VA Medical Center". undefined are not yet recruiting, 22 are recruiting, 42 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 125 completed trials in Atlanta VA Medical Center, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta VA Medical Center, 3 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 38 trials that are defined as “Not Applicable".